Trump administration will fund new research on controversial psychedelic drug ibogaine
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
Read original article on Medical Xpress - latest medical and health news stories →